Clinical impact of routine response assessment after preoperative chemotherapy in patients with gastric cancer

Sander J M van Hootegem(Erasmus MC), Bas P. L. Wijnhoven(Erasmus MC Cancer Institute), Alexander Bradshaw(Freeman Hospital), Sjoerd M. Lagarde(University of Amsterdam), Alexander W. Phillips(Royal Victoria Infirmary), Carlo Alberto De Pasqual(University of Verona), Ben M. Eyck(Erasmus MC Cancer Institute), Bianca Mostert(Erasmus MC)

BJS Open

September 5, 2023

10.1093/bjsopen/zrad093

Cited by 0

Related Papers

Ten-Year Outcome of Neoadjuvant Chemoradiotherapy Plus Surgery for Esophageal Cancer: The Randomized Controlled CROSS Trial

|Journal of Clinical Oncology|2021|788

Extended Transthoracic Resection Compared With Limited Transhiatal Resection for Adenocarcinoma of the Mid/Distal Esophagus

|Annals of Surgery|2007|709

Comparative genomic hybridization of cancer of the gastroesophageal junction: deletion of 14Q31-32.1 discriminates between esophageal (Barrett's) and gastric cardia adenocarcinomas.

|PubMed|1999|140

Neoadjuvant chemoradiotherapy followed by active surveillance versus standard surgery for oesophageal cancer (SANO trial): a multicentre, stepped-wedge, cluster-randomised, non-inferiority, phase 3 trial

|The Lancet Oncology|2025|95

Updated protocol of the SANO trial: a stepped-wedge cluster randomised trial comparing surgery with active surveillance after neoadjuvant chemoradiotherapy for oesophageal cancer

|Trials|2021|91